Epstein-Barr virus infection and single nucleotide polymorphisms in the promoter region of interleukin 10 gene in patients with Hodgkin lymphoma

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 11, 2007, Pages 1691-1696

  Da Silva, Glenda Nicioli ^a   Bacchi, Maura Moscardi ^b   Rainho, Cláudia Aparecida ^a   Elgui De Oliveira, Deilson ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Consultoria em Patologia Laboratory ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INTERLEUKIN 10;

ADOLESCENT; ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CHILD; EPSTEIN BARR VIRUS; FOLLICULAR LYMPHOMA; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IL10 GENE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS CARCINOGENESIS; VIRUS INFECTION;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HODGKIN DISEASE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PSEUDOLYMPHOMA;

EID: 35948976059     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Hodgkin T. On some morbid appearances of the absorbent glands and spleen. Med Chir Trans. 1832;17:69-114.
2. Haluska F, Brufsky AM, Canellos GP. The cellular biology of the Reed-Sternberg cell. Blood. 1994;84:1005-1019.
3. Flavell KJ, Murray PG. Hodgkin's disease and the Epstein-Barr virus. Mol Pathol. 2000;53:262-269.
4. Thomas RK, Re D, Wolf J, Diehl V. Part 1: Hodgkin's lymphoma - molecular biology of Hodgkin and Reed-Sternberg cells. Lancet. 2004;5:11-18.
5. Yung L, Linch D. Hodgkin's lymphoma. Lancet. 2003;361:943-951.
6. Weiss LM, Chen YY, Liu X-F, Shibata D. Epstein-Barr virus and Hodgkin's disease: a correlative in situ hybridization and polymerase chain reaction study. Am J Pathol. 1991;139:1259-1265.
7. Hummel M, Anagnotopoulos I, Dallenbach F, Korbjunh P, Dimmeler C, Stein H. EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV products. Br J Haematol. 1992;82:689-694.
8. Ambinder RF, Browning PJ, Lorenzana I, et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood. 1993;81:462-467.
9. Armstrong AA, Alexander FE, Paes RP, et al. Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol. 1993;142:1683-1688.
10. Jarret RF. Viruses and Hodgkin's lymphoma. Ann Oncol. 2002;13:23-29.
11. Gallagher A, Perry J, Shield L, Freeland J, Mackenzie J, Jarret RF. Viruses and Hodgkin disease: no evidence of novel herpes viruses in non-EBV-associated lesions. Int J Cancer. 2002;101:259-264.
12. Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood. 2002;99:4283-4297.
13. Maggio E, Van Der Berg A, Diepstra A, Kluiver J, Visser L, Poppema S. Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues. Ann Oncol. 2002;13:52-56.
14. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest. 2000;117:1162-1172.
15. Turner DM, Williams DM, Sankaran D, Lazarus SM, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1-8.
16. Doncel AM, Rubio A, Arroyo R, et al. Interleukin-10 polymorphism in Spanish multiple sclerosis patients. J Neuroimmunol. 2002;131:168-172.
17. Mok CC, Lanchbury JS, Chan DW, Lau CS. Interleukin-10 promoter polymorphism in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheumatol. 1998;41:1090-1095.
18. Suarez A, Castro P, Alonso R, Mozo L, Gutierrez C. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation. 2003;75:711-717.
19. Myhr KM, Vagnes KS, Maroy TH, Aarseth JH, Nyland CA, Vedeler CA. Interleukin-10 promoter polymorphisms in patients with Guillain- Barrésyndrome. J Neuroimmunol. 2003;139:81-83.
20. Pelletier R, Pravica V, Perrey C, Xia D. Ferguson RM, Hutchinson Orosz C. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation. Transplantation. 2000;70:674-680.
21. Tambur AR, Ortegel JW, Bem Ari Z, et al. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation. 2001;71:1475-1480.
22. Eskdale J, Keijsers V, Huizinga T, Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immunol. 1999;1:151-155.
23. Ramos-da-Silva S, Elgui-de-Oliveira D, Borges L, Bacchi CE. Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma in Brazil. Braz J Med Biol Res. 2006;39:573-580.
24. Elgui-de-Oliveira D, Bacchi MM, Abreu ES, Niero-Melo L, Bacchi CE. Hodgkin disease in adult and juvenile groups from two different geographic regions in Brazil: characterization of clinicopathologic aspects and relationship with Epstein-Barr virus infection. Am J Clin Pathol. 2002;118:25-30.
25. Goodman LA. On simultaneous confidence intervals for multinomial proportions. Tecnometrics. 1965;7:247-254.
26. Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristic in international data. Int J Cancer. 1997;70:375-382.
27. Kuppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Ver Immunol. 2003;3:801-812.
28. Papadaki T, Stamatopoulos K. Hodgkin disease immunopathogenesis: long-standing questions, recent answers, further directions. Trends Immunol. 2003;24:508-511.
29. Chang YH, Huang XN, Wu CN, Shiau MY. Association of IL-10 A-592C and T-819C polymorphism with type 2 diabetes mellitus. Hum Immunol. 2005;66:1258-1263.
30. Huang YC, Tsukamoto K, Sharma V. Interleukin-10 promoter gene polymorphisms have no clear influence on interleukin-10 protein secretion in AIDS-associatcd B-cell lines. Biochem Biophysis Res Commun. 2005;335:529-535.
31. Abbas Z, Moatter T, Hussainy A, Jafri W. Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3. World J Gastroenterol. 2005;11:6656-6661.
32. Beck A, Pazolt D, Grabenbauer GG, et al. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease. J Pathol. 2001;194:45-151.
33. Muti G, Klersy C, Baldanti F, et al. Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders. Br J Haematol. 2003;122:927-933.
34. Poppema S. Immunobiology and pathophysiology of Hodgkin lymphomas. Hematology. 2005;231-238.
35. Stanilova SA, Miteva LD, Karakolev ZT, Stefanov CS. Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Med. 2006;32:260-266.
36. Van der Lin M, Westendorp RGJ, Sturk A, Bergman W, Huizinga TWJ. High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus. J Investig Med. 2000;48:327-334.
37. Hutchinson IV, Pravica V, Hajeer A. Identification of high and low responded to allografts. Rev Immunogenet. 1991;1:323-333.
38. Dukers DF, Jaspars LH, Vos W, et al. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease. J Pathol. 2000;190:143-149.
39. Munro LR, Johnston PW, Marshall SJ. et al. Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma. Leuk Lymphoma. 2003;44:2083-2088.
40. Bohlen H, Kessler M, Sextro M, Diehl V, Tesch H. Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Ann Hematol. 2000;79:110-113.
41. Moraes MO, Santos AR, Schonkeren JJM, et al. Interleukin-10 promoter haplotypes are differently distributed in the Brazilian versus the Dutch population. Immunogenetics. 2003;54:896-899.
42. Albuquerque AG, Moraes M, Vanderborght PR, et al. Tumor necrosis factor and interleukin-10 gene promoter polymorphisms in Brazilian population and in Terena Indians. Transplant Proc. 2004;16:825-826.